Facebook Users

Will EROX go up?

EROX Human Pheromone Sciences Inc. featured news, full reports, and detailed charts

Human Pheromone Sciences Inc. (EROX/EROX.OB) Wrap Up:

Human Pheromone Sciences, Inc. engages in the research, development, manufacture, and marketing of consumer products containing synthetic human pheromones and other mood enhancing compounds. It offers a line of fragrance and toiletry products for men and women under the trademark Natural Attraction. The synthesized human pheromones provide the technology of a component that are intended to have application and usage in cosmetics, treatments, cleansing, over-the-counter health supplements, and home and vehicle environmental products. The company has granted non-exclusive rights to the Natural Attraction products in the United States, Europe, and Japan. It licenses its technology and products,...
www.naturalattraction.com
2 Employees
Founded in 1989

Human Pheromone Sciences Inc. (EROX:OTC Bulletin Board Market)

LAST $0.16 USD
CHANGE TODAY 0.00 0.00%
VOLUME 0.0
As of November 19, 2009 All times are local (Market data by Reuters is delayed by at least 15 minutes).

Snapshot of Human Pheromone Sciences Inc. (EROX)

OPEN
--
PREVIOUS CLOSE
$0.16
DAY HIGH
--
DAY LOW
--
52 WEEK HIGH
06/15/09 - $0.51
52 WEEK LOW
02/26/09 - $0.11
MARKET CAP
664.3K
AVERAGE VOLUME 3 mo
13.0K
DILUTED EPS TTM
$-0.08
SHARES OUTSTANDING
4.2M
EROX Does Not Pay Dividends
P/E TTM
NM
K = Thousands  M = Millions  B = Billions

EROX Top Compensated Officers

Mr. William P. Horgan
Chairman of the Board, Chief Executive Office...
Age: 61
Total Annual Compensation: $221.5K
Mr. Gregory S. Fredrick
Chief Financial Officer, Principal Accounting...
Age: 54
Total Annual Compensation: $120.0K

Executives, Board Directors

Compensation as of Fiscal Year 2008.

Key developments for Human Pheromone Sciences Inc. (EROX)

Human Pheromone Sciences Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2009

Human Pheromone Sciences Inc. announced unaudited earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company has reported net revenues of $273,000 represented a 4% increase from the revenues of $262,000 in the prior year period, and resulted in net income of $10,000 or $0.00 per diluted share as compared with a net loss of $30,000 or $0.01 per diluted share for the same period of 2008. Income from operations was $10,000 against loss from operations of $37,000 reported last year. For the nine months, the company has reported net revenues of $662,000 were 13% lower than the previous year's $764,000, resulting in a net loss of $255,000 or $0.06 per diluted share as compared with a net loss of $181,000 or $0.04 per diluted share in the first nine months of 2008. Loss from operations was $256,000 against $205,000 reported last year.

Human Pheromone Sciences, ACI Inc. and Marilyn Miglin Announce the Introduction of Their Initial Fragrance on Home Shopping Network

Human Pheromone Sciences Inc. and Marilyn Miglin LLC announced the initial product generated by their collaborative efforts to create a fragrance collection, Marilyn Miglin'sSixth Sense, will be introduced on Home Shopping Network (HSN). The parties were introduced through New York City based BIG (Brand Intelligence Group Inc.) who handles the branding and licensing of several fashion, beauty and lifestyle brands. The fragrance is a unique addition to Marilyn Miglin's highly successful portfolio of fragrances with a sensory-dynamic quality that enhances allurement and self-assurance offering a truly new experience in fragrance.

Human Pheromone Sciences Inc. Reports Earnings Results for the Three and Six Months Ended June 30, 2009

Human Pheromone Sciences Inc. announced results for the three and six months ended June 30, 2009. For the three month period ending June 30, 2009, net revenues of $224,000 represented a 5% decrease from the revenues of $236,000 in the prior year period, and resulted in a net loss of $84,000 or $0.02 per share as compared with a net loss of $88,000 or $0.02 per share for the same period of 2008. Loss from operations was $84,000 compared to $95,000 in the previous year period. For the six month period ending June 30, 2009, net revenues of $389,000 were 23% lower than the previous year's $502,000, resulting in a net loss of $265,000 or $0.06 per share as compared with a net loss of $151,000 or $0.04 per share in the first six months of 2008. At June 30, 2009, the company reflected cash balance of $542,000 compared with $907,000 at December 31, 2008. Loss from operations was $266,000 compared to $168,000 in the previous year period.

otc, otcbb, pinksheet, EROX, ob Human Pheromone Sciences Inc.

EROX Competitors

Company Last Change
Estee Lauder Companies Inc $47.86 USD +0.25
L'Oreal €72.23 EUR +0.27
Procter & Gamble Co $61.80 USD -0.35
Unilever 1,787 GBX +12.00
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation EROX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 14.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x

EROX

 | 

EROX transactions

Type
Date
Target
No transactions in the last 6 months.

More Recent News About Human Pheromone Sciences Inc.

Would you like to leave a comment about Human Pheromone Sciences Inc. EROX/EROX.OB

Besides Human Pheromone Sciences Inc. there is more great information available at Realpennies.com